| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | 0.016 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | Panobinostat | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |